Agency / Source: SCHOTT North America

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SCHOTT Pharma Opens State-of-the-Art Production Facility in Lukácsháza, Hungary - After breaking ground in October 2022 and fresh of its IPO in September 2023, SCHOTT Pharma opened the doors to an entirely new production facility for high-quality prefillable glass syringes in Hungary - SCHOTT-Pharma.com
SCHOTT Pharma Opens State-of-the-Art Production Facility in Lukácsháza, Hungary

 

PRZOOM - /newswire/ - Lukácsháza, Hungary, 2024/06/14 - After breaking ground in October 2022 and fresh of its IPO in September 2023, SCHOTT Pharma opened the doors to an entirely new production facility for high-quality prefillable glass syringes in Hungary - SCHOTT-Pharma.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Manufacturing / Robotics Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• After EUR 76 million (HUF 28,044 billion) investment and 1.5 years of construction, SCHOTT Pharma opens its newest production facility in Lukácsháza, Hungary;
• Expanding production capacity will support pharma megatrends and market growth for prefillable syringes made of specialty glass;
• With financial support from the local government, the facility brings over 120 new jobs to the area.

Supported by a EUR 9 million (HUF 3,321 billion) investment from the local government, SCHOTT Pharma’s double-digit million Euro investment is realized today with the opening of a facility that creates over 120 jobs. With this move, SCHOTT Pharma is expanding its global capacities for strategically important high-value solutions that address key pharma trends. At the same time, the company is strengthening its competitiveness in Europe and the supply security for major pharmaceutical companies and contract manufacturing organizations. To supply the fast and dynamically growing market, SCHOTT Pharma plans to further invest a multi-million Euro amount in Hungary in prefillable syringes in the next years.

“With an increasing number of drugs being stored in prefillable glass syringes from GLP-1 drugs to critical vaccines and innovative biologics, the manufacturing beginning at this site today will continue to support major trends in the pharma industry,” says Andreas Reisse, CEO of SCHOTT Pharma.

As evidenced by their growing demand in the healthcare industry, these high-quality prefillable glass syringes not only offer a stable, long-term storage solution for drugs, but also a safe and convenient delivery system for patients and clinicians.

Drug containment and delivery play a critical role in medication protocols. Traditionally, a newly developed drug is launched in vials, with healthcare providers using disposable syringes for extraction and administration. Today, more and more pharmaceutical companies are moving towards filling medicines directly into prefillable syringes to enable storage and administration in one, streamlining the injection process for healthcare professionals and improving the accuracy of dosing for patients.

SCHOTT Pharma’s Hungarian site, that was inaugurated in Lukácsháza today, builds on the company’s existing foundation and pharmaceutical production skillset in the area, which already plays an important role in supplying the global industry with drug containment systems today. Following the high-end processes and advanced quality assurance found in SCHOTT Pharma’s global production network in 14 countries, the facility is equipped with state-of-the-art machinery. The new site is the second site where the company manufactures glass syringes, in addition to the site in St. Gallen in Switzerland.

About SCHOTT Pharma

Human health matters. That is why SCHOTT Pharma (schott-pharma.com) designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world. The portfolio comprises drug containment solutions and delivery systems for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of over 4,600 people from over 60 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house and a state-of-the-art R&D center in Switzerland, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA is headquartered in Mainz, Germany and listed on the Frankfurt Stock Exchange as part of the SDAX. It is part of SCHOTT AG, which is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1,800 customers including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of EUR 899 million in the fiscal year 2023.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Manufacturing / Robotics Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: SCHOTT North America

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Manufacturing / Robotics articles,
CATCH Visitors via Your Competitors Announcements!


SCHOTT Pharma Opens State-of-the-Art Production Facility in Lukácsháza, Hungary

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Prefillable Glass Syringe | SCHOTT Pharma
Contact: Lea Kaiser - SCHOTT.com 
Lea Kaiser - SCHOTT.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SCHOTT North America securities in any jurisdiction including any other companies listed or named in this release.

Manufacturing / Robotics via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From SCHOTT North America / Company Profile


Read Manufacturing / Robotics Most Recent Related Press Releases:

Czech Automation Engineering Business has become Part of Atlas Copco Group
ABB Launches Do More wth Digital Campaign to Accelerate Digitalization Across Process Industries
Impact Absorber Made of BASF Polyamide Particle Foam Ultramid® Expand Receives the 2nd Prize of the Prestigious SPE Automotive Award
HUBER+SUHNER Selected by MDA Space as Part of MDA AURORA™ Supply Chain
SCHOTT Produces Final Segment Blanks for World’s Largest Telescope Mirror in ESO ELT
ABB Flowmeters with Ethernet-APL Awarded FieldComm Group Certification
Encina and BASF Establish Long-Term Partnership for Supply of Circular Raw Materials
Topsoe, ABB and Fluor Form Alliance to Develop Standardized Concept for SOEC Electrolyzer Factory
TRUMPF to Showcase TruHeat VCSEL Drying Solutions for Advanced, Cost-effective Electrode Manufacturing At Battery Show Europe
LANXESS to Showcase Comprehensive Portfolio for Battery Production

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com

Visit  JobsWare.com







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today